logo-loader
viewPfizer

FTSE gains on optimism a Covid-19 vaccine could be approved this week

FTSE 100 headed higher at start of the week thanks to progress on the vaccine front and reports that the November lockdown cut coronavirus infections by a third. London's leading index advanced 4 points to 6,372 in early trading.  

The UK is expected to authorise the COVID-19 vaccine candidate developed by Pfizer Inc. (NYSE:PFE) and BioNTech this week. The rollout could start as early as December 7, while the country has secured 40mln doses.  

Frasers Group PLC (LON:FRAS), the sports retail group run by Mike Ashley, has offered funding of up to £50mln to struggling retailer Arcadia Group. The Topshop owner is facing administration as early as Monday, risking 13,000 jobs.  

HSBC Holdings PLC (LON:HSBA) is mulling a complete exit from its US retail banking operations. The FTSE 100 firm has been struggling to compete with much bigger players in the country.  

Symphony Environmental Technologies PLC (LON:SYM) shares shot after a highly successful coronavirus (COVID-19) test of anti-viral gloves and masks containing the company’s d2pAM antimicrobial technology. The assessment was carried out in Brazil.

CentralNic Group PLC saw revenue more than double year-on-year in the first nine months of 2020, with record organic revenue growth of 17%. The internet platform operator posted revenue up 118%.

Scotgold Resources Ltd (LON:SGZ) is on course to start Phase 1 production at the Cononish gold and silver mine in the Trossachs later today. This phase targets average annual gold equivalent production of 9,910 ounces.

Quick facts: Pfizer

Price: 36.7 USD

NYSE:PFE
Market: NYSE
Market Cap: $203.99 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

SourceBio International reveal revenues rose to over £50m for 2020 and set...

SourceBio International PLC's (LON:SBI) Jay LeCoque talks to Proactive London's Katie Pilbeam about their 2020 results.  LeCoque explains what drove revenues for the 12 months ended December 31, 2020, up to £50.7mln, from £21.2mln in 2019. Another headline figure was the underlying...

2 hours, 1 minute ago

2 min read